Patent Reform Speeds Drug Development, At Least At The Signing Ceremony
This article was originally published in The Pink Sheet Daily
President Obama announce seven initiatives to help move ideas from the lab to market as he signs the Leahy-Smith America Invents Act.
You may also be interested in...
Pharmaceuticals falls below computers, communications and electrical equipment in “patent intensity” – the ratio of patents to jobs – according to a Patent and Trademark Office report on the importance of intellectual property to the U.S. economy.
The Patent and Trademark Office issued a proposed fee schedule as part of its implementation of the Leahy-Smith America Invents Act; post-grant review fees could deter use of the procedure, Lilly’s general counsel says.
At President Obama's urging the CEOs of Lilly and Cisco met with Commerce Department officials to hammer out their differences to get the legislation through Congress.